RPS24 knockdown inhibits colorectal cancer cell migration and proliferation in vitro

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• Ribosomal proteins, beyond protein synthesis, have extra-ribosomal functions linked to diseases like Diamond-Blackfan anemia.
• The specific role of RPS24 in human colon cancer pathogenesis remains largely unexplored.
• Understanding RPS24's function is crucial for identifying new therapeutic strategies in oncology.

Purpose of the Study:

• To investigate the role and significance of RPS24 in human colon cancer.
• To determine the impact of RPS24 gene inhibition on colon cancer cell behavior.
• To evaluate RPS24 as a potential biomarker for colon cancer diagnosis and therapy.

Main Methods:

• Utilized a lentivirus shRNA approach to significantly inhibit RPS24 gene expression in human colon cancer cell lines (HCT116 and HT-29).
• Assessed the effects of RPS24 knockdown on key cancer cell behaviors including proliferation, colony formation, and migration.
• Analyzed cell cycle progression to identify specific cellular arrests induced by RPS24 inhibition.

Main Results:

• RPS24 gene expression was successfully and significantly inhibited in HCT116 and HT-29 colon cancer cells.
• Knockdown of RPS24 markedly suppressed colon cancer cell proliferation, colony formation, and migration.
• RPS24 inhibition led to cell cycle arrest specifically in the S phase.

Conclusions:

• This study provides the first evidence demonstrating a critical role for the RPS24 gene in human colon cancer.
• RPS24 functions as a significant regulator of colon cancer cell growth and metastasis.
• The RPS24 gene presents a promising biomarker candidate for colon cancer therapy and holds potential for diagnostic applications.